Zentalis Pharmaceuticals's total assets for Q1 2026 were $253.07M, a decrease of -12.42% from the previous quarter. ZNTL total liabilities were $70.39M for the fiscal quarter, a -3.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.